Core Points - The company held its 2024 Annual General Meeting to discuss various proposals, including the 2025 compensation plan for directors and senior management, and the authorization for the board to issue shares to specific targets [1][2][3] - The company reported a revenue of 892 million yuan in 2024, a 4.41% increase from the previous year, with significant growth in the optical components business [4][6] - The net profit attributable to shareholders for 2024 was 209 million yuan, a decrease of 14.25% compared to the previous year, influenced by increased R&D expenses and the absence of one-time gains from land acquisition [4][5] - The company plans to distribute a cash dividend of 8.50 yuan per 10 shares, totaling approximately 94 million yuan, marking a cash dividend ratio of 45.21%, the highest since its listing [31][32] Meeting Agenda - The meeting was scheduled for May 20, 2025, at 14:30, with a detailed agenda including reports from the board and supervisory committee, financial statements, and various proposals for shareholder approval [1][2] - The meeting included provisions for shareholder participation, allowing for both on-site and online voting [2][3] Financial Performance - The company achieved a total asset value of approximately 2.3 billion yuan by the end of 2024, reflecting a 9.85% increase from the previous year [19][21] - The total liabilities increased by 29.17% to approximately 361 million yuan, primarily due to an increase in short-term borrowings [22][24] - The company’s equity rose by 6.87% to approximately 1.94 billion yuan, with significant changes in stock repurchase obligations and minority interests [24][25] Strategic Initiatives - The company is focusing on enhancing its technological capabilities and market competitiveness through a dual-engine strategy, aiming for high-end scientific instrument production and consumer-oriented optical components [4][6] - A talent development plan is in place to foster a younger management team, with over 60% of mid-to-senior management being under 40 years old [6][15] Governance and Compliance - The board of directors and supervisory committee have adhered to legal and regulatory requirements, ensuring the legality and effectiveness of their operations [11][18] - The company has implemented a stock incentive plan to attract and retain talent, with 72,100 shares granted to 146 employees [12][13]

证券代码：603297 二〇二五年五月二十日 宁波永新光学股份有限公司 2024 年年度股东大会会议资料 宁波永新光学股份有限公司 2024年年度股东大会 会议资料 | | | | 一、2024 年年度股东大会会议议程 2 | | --- | | 二、2024 年年度股东大会会议须知 4 | | 三、2024 年年度股东大会会议议案 5 | | 议案一：《2024 年度董事会工作报告》 5 | | 议案二：《2024 年度监事会工作报告》 13 | | 议案三：《2024 年度财务决算报告》 15 | | 议案四：《关于 2024 年度利润分配预案的议案》 19 | | 议案五：《2024 年年度报告全文及摘要》 20 | | 议案六：《关于公司董事、高级管理人员 2025 年度薪酬方案的议案》 21 | | 议案七：《关于公司监事 2025 年度薪酬方案的议案》 23 | | 议案八：《关于续聘会计师事务所的议案》 24 | | 议案九：《关于提请股东大会授权董事会以简易程序向特定对象发行股票的议案》 | | 28 | | 议案十：《关于修订<公司章程>的议案》 32 | | 四、2024 年年度股东大会听 ...

宁波永新光学股份有限公司 关于召开2024年年度网上业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券代码：603297 证券简称：永新光学 公告编号：2025-022 会议召开方式：文字网络互动 会 议 召 开 地 点 ： 证 券 日 报 网 路 演 平 台 （http://www.zqrb.cn/huiyi/lyhd/index.html） 三、参加人员 会议召开时间：2025 年 5 月 21 日 15:00-16:00 会议召开方式：文字网络互动 会议召开地点：证券日报网路演平台（http://www.zqrb.cn/huiyi/lyhd/ind ex.html） 投资者可于 2025 年 5 月 20 日 17:00 前通过公告中的联系电话、电子邮 箱联系公司，提出所关注的问题，公司将在说明会上就投资者普遍关注的问题 进行回答。 一、说明会类型 宁波永新光学股份有限公司（以下简称"公司"）已于 2025 年 4 月 26 日在 上海证券交易所网站（www.sse.com.cn）披露 ...

Core Viewpoint - The company reported its 2024 annual results and 2025 Q1 results, showing a slight increase in revenue but a decline in net profit for 2024, while Q1 2025 showed growth in both revenue and net profit [1][3]. Group 1: Financial Performance - In 2024, the company achieved operating revenue of 892 million yuan, a year-on-year increase of 4.4%, and a net profit attributable to shareholders of 209 million yuan, a year-on-year decrease of 11.4% [1]. - For Q1 2025, the company reported operating revenue of 220 million yuan, a year-on-year increase of 1.8%, and a net profit attributable to shareholders of 56 million yuan, a year-on-year increase of 22.2% [1]. - The performance in 2024 and Q1 2025 met expectations, indicating a clear trend of recovery in the microscope sector [1]. Group 2: Business Segments - The optical microscope business generated sales revenue of 356 million yuan in 2024, a year-on-year decrease of 13.92%, influenced by industry demand recovery and equipment update policies, with a quarter-on-quarter sales increase of 8.53% in Q4 [1]. - The high-end microscope segment is experiencing rapid growth, achieving over 5% domestic substitution, with high-end microscopes accounting for approximately 40% of total microscope sales [1]. - The optical components business achieved sales revenue of 513 million yuan, a year-on-year increase of 22.56%, with barcode scanning business recovering quickly and LiDAR products reaching mass production, surpassing 100 million yuan in revenue [1]. Group 3: Research and Development - The company continued to invest in R&D, with expenditures reaching 98.5 million yuan in 2024, a year-on-year increase of 7.34%, representing 11.33% of main business revenue [2]. - The company launched several new microscopes priced between 200,000 and 3 million yuan, being one of the few domestic manufacturers capable of independently developing and producing super-resolution and confocal optical microscopes [2]. - The company has established long-term partnerships with several leading domestic clients in the semiconductor sector, with ultra-precision optical components already applied in maskless lithography equipment and semiconductor optical measurement devices [2]. Group 4: Profit Forecast and Valuation - The profit forecasts for 2025-2027 have been adjusted, with expected net profits of 302 million yuan, 349 million yuan, and 400 million yuan respectively, reflecting a downward revision for 2025-2026 due to the poor performance of the optical microscope business in 2024 [3]. - The current stock price corresponds to a price-to-earnings (PE) ratio of 32, 28, and 24 for 2025-2027, respectively, with the company being a leading optical manufacturer in China [3]. - The company is expected to continue enhancing its business scale and industry position, with a target PE of 42x for 2025, indicating over 20% upside potential from the current valuation [3].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company reported a revenue of 892 million yuan for 2024, a year-on-year increase of 4.4%, and a net profit attributable to shareholders of 209 million yuan, a decrease of 11.4%. In Q1 2025, the company achieved a revenue of 220 million yuan, a year-on-year increase of 1.8%, and a net profit of 56 million yuan, a year-on-year increase of 22.2% [4][6] Financial Data and Profit Forecast - Total revenue for 2024 is projected at 892 million yuan, with a year-on-year growth rate of 4.4%. For Q1 2025, revenue is 220 million yuan, with a growth rate of 1.8%. The estimated revenues for 2025, 2026, and 2027 are 1,165 million yuan, 1,411 million yuan, and 1,673 million yuan respectively, with growth rates of 30.7%, 21.1%, and 18.5% [5][8] - The net profit attributable to shareholders for 2025 is estimated at 302 million yuan, with a growth rate of 45.0%. The projected net profits for 2026 and 2027 are 349 million yuan and 400 million yuan, with growth rates of 15.5% and 14.5% respectively [5][8] - The earnings per share for 2025 is estimated at 2.72 yuan, with a projected PE ratio of 32 [5][8] Business Performance Insights - The optical microscope business generated sales of 356 million yuan in 2024, a decline of 13.92%, while the optical components business achieved sales of 513 million yuan, an increase of 22.56%. The high-end microscope segment has seen significant growth, with over 5% domestic substitution achieved [6] - The company continues to invest in R&D, with expenditures reaching 98.5 million yuan in 2024, accounting for 11.33% of main business revenue. New microscope products priced between 200,000 and 3 million yuan have been launched, and the company has established long-term partnerships in the semiconductor sector [6] Profit Forecast Adjustments - The profit forecasts for 2025 and 2026 have been adjusted downwards, with new estimates for 2025 and 2026 net profits set at 302 million yuan and 349 million yuan respectively. The current stock price corresponds to PE ratios of 32, 28, and 24 for 2025, 2026, and 2027 respectively, indicating over 20% upside potential based on a target PE of 42 for 2025 [6]

Core Viewpoint - The company reported a revenue of 892 million yuan for 2024, a year-on-year increase of 4.4%, with optical components and microscope revenues at 513 million and 356 million yuan respectively, showing a year-on-year increase of 23% and a decrease of 14% [1] Group 1: Financial Performance - The net profit attributable to shareholders for 2024 was 209 million yuan, a year-on-year decrease of 11.4%, primarily due to the absence of one-time gains from land acquisition and increased R&D expenses; however, the non-recurring net profit attributable to shareholders grew by 14.3% to 185 million yuan [1] - In Q4 2024, revenue was 241 million yuan, with a year-on-year and quarter-on-quarter change of -0.9% and +8.5% respectively; net profit attributable to shareholders was 68 million yuan, with a year-on-year and quarter-on-quarter change of +10.9% and +68.0% respectively, meeting market expectations [1] - For Q1 2025, revenue was 220 million yuan, with a year-on-year and quarter-on-quarter change of +1.8% and -8.9% respectively; net profit attributable to shareholders was 56 million yuan, with a year-on-year and quarter-on-quarter change of +22.2% and -18.5% respectively, also meeting market expectations [1] Group 2: Industry Trends - The demand for microscopes is showing signs of recovery from a low point, with a strategic opportunity for domestic substitution; despite a 14% year-on-year decline in microscope revenue to 356 million yuan in 2024, sales increased by 8.5% quarter-on-quarter in Q4 2024, indicating a potential recovery in 2025 [2] - The company is making significant investments in high-end microscopes and has achieved technological breakthroughs, such as leading a national major instrument project for "multi-modal nano-resolution microscopy," indicating a broad space for domestic substitution in the long term [2] Group 3: Optical Components and Growth Areas - The company is diversifying its optical components business, with significant growth in barcode scanning due to customer inventory adjustments and recovering overseas demand; collaborations with clients like Zebra and Honeywell are expected to contribute substantial incremental revenue [3] - In the field of LiDAR, the company has established close partnerships with leading clients such as Hesai and Valeo, with revenue surpassing 100 million yuan in 2024; the penetration rate of LiDAR is expected to increase rapidly, driving continued high revenue growth for the company [3] - In the medical optics sector, the company has seen rapid growth in endoscope optical components and achieved technological breakthroughs in surgical microscope optical components, indicating a positive outlook for new growth engines [3] Group 4: Profit Forecast and Valuation - The company maintains a forecast of 332 million yuan for net profit attributable to shareholders in 2025 and introduces a revenue forecast of 1.459 billion yuan and net profit of 428 million yuan for 2026; the current stock price corresponds to P/E ratios of 29x and 22x for 2025 and 2026 respectively [4] - The target price has been raised by 19% to 104.66 yuan, corresponding to P/E ratios of 35x and 27x for 2025 and 2026, indicating an upside potential of 22% [4]

Investment Rating - The report maintains the investment rating for the company [1] Core Views - The company is projected to experience significant revenue growth, with estimated revenues increasing from 891.76 million in 2024 to 1642.01 million by 2027, reflecting a compound annual growth rate (CAGR) of approximately 20.65% [5][7] - Net profit is expected to rise from 208.58 million in 2024 to 377.76 million in 2027, indicating a robust growth trajectory with a CAGR of about 28.05% [5][7] - The gross margin is anticipated to improve from 39.03% in 2024 to 44.98% in 2027, showcasing enhanced operational efficiency [5][7] Financial Summary - **Revenue Forecast**: - 2024: 891.76 million - 2025: 1118.01 million (growth rate: 25.37%) - 2026: 1361.01 million (growth rate: 21.74%) - 2027: 1642.01 million (growth rate: 20.65%) [5][7] - **Net Profit Forecast**: - 2024: 208.58 million - 2025: 241.55 million (growth rate: 15.81%) - 2026: 295.02 million (growth rate: 22.13%) - 2027: 377.76 million (growth rate: 28.05%) [5][7] - **Key Financial Ratios**: - PE ratio is projected to decrease from 45.73 in 2024 to 25.25 in 2027, indicating improved valuation metrics [5][7] - PB ratio is expected to decline from 4.92 in 2024 to 3.91 in 2027, reflecting a more attractive investment proposition [5][7] - **Cash Flow**: - Operating cash flow is forecasted to decrease from 263.31 million in 2024 to 226.69 million in 2025, before increasing to 424.05 million by 2027 [6][7]

Investment Rating - The report maintains the investment rating for the company [1] Core Views - The company is projected to experience significant revenue growth, with estimated revenues increasing from 891.76 million in 2024 to 1642.01 million by 2027, reflecting a compound annual growth rate (CAGR) of approximately 20.65% [5][7] - The net profit attributable to the parent company is expected to rise from 208.58 million in 2024 to 377.76 million in 2027, indicating a robust growth trajectory with a CAGR of about 28.05% [5][7] - The gross margin is anticipated to improve from 39.03% in 2024 to 44.98% in 2027, showcasing enhanced operational efficiency [5][7] Financial Summary - **Revenue Forecast**: - 2024: 891.76 million - 2025: 1118.01 million (growth rate: 25.37%) - 2026: 1361.01 million (growth rate: 21.74%) - 2027: 1642.01 million (growth rate: 20.65%) [5][7] - **Net Profit Forecast**: - 2024: 208.58 million - 2025: 241.55 million (growth rate: 15.81%) - 2026: 295.02 million (growth rate: 22.13%) - 2027: 377.76 million (growth rate: 28.05%) [5][7] - **Key Financial Ratios**: - PE ratio is projected to decrease from 45.73 in 2024 to 25.25 in 2027, indicating improved valuation metrics [5][7] - PB ratio is expected to decline from 4.92 in 2024 to 3.91 in 2027, reflecting a more attractive investment proposition [5][7] - **Cash Flow**: - Operating cash flow is forecasted to decrease from 263.31 million in 2024 to 226.69 million in 2025, before increasing to 424.05 million by 2027 [6][7]

Core Viewpoint - Yongxin Optical has announced a record-high cash dividend distribution for 2024, reflecting strong confidence in future operations and a commitment to shareholder value [1] Financial Performance - In 2024, Yongxin Optical achieved a revenue of 892 million RMB, marking a year-on-year increase of 4.41%, setting a new historical high for revenue [4] - The net profit attributable to shareholders was 209 million RMB, a decrease of 11.37% year-on-year, while the net profit excluding non-recurring items increased by 14.25% to 185 million RMB [4] - In Q1 2025, the company reported a revenue growth of 1.77% and a net profit increase of 22.16% year-on-year, indicating a positive trend in performance [4] Dividend Distribution - The total proposed cash dividend for 2024 is 94.2962 million RMB (including tax), which accounts for 45.21% of the net profit attributable to shareholders, the highest dividend payout ratio since the company went public [1] Business Segments - The core business includes scientific instruments and optical components, with a focus on high-end microscopes and LiDAR optical components as key growth areas [1] - Sales revenue from optical microscopes reached 356 million RMB, a year-on-year decline of 13.92%, primarily due to weak industry demand; however, the sales proportion of high-end microscopes increased to 40% [1] - The LiDAR optical components business surpassed 100 million RMB in revenue, becoming a new growth driver for the company [1] R&D and Innovation - In 2024, R&D investment reached 98.5 million RMB, a year-on-year increase of 7.34%, accounting for 11.33% of main business revenue [2] - The company is leading multiple national-level technology projects, including a major project on multi-modal nano-resolution microscope equipment [2] - Collaborations with prestigious universities have been established to create a closed-loop ecosystem for research, talent cultivation, and market feedback [2] Strategic Focus - For 2025, the company aims to enhance its position in the optical perception field through a strategy focused on precision manufacturing and innovation [3] - The company plans to accelerate domestic high-end replacement and improve operational efficiency through enhanced information technology in sales, supply chain, and production processes [3]

Investment Rating - The report does not explicitly state an investment rating for the industry Core Insights - The lithography process is the most technically challenging, costliest, and time-consuming step in chip manufacturing, accounting for approximately 30% of costs and 40-50% of time in the manufacturing process [7][10][12] - The lithography process involves multiple steps, including surface treatment, coating, exposure, development, and inspection, with advanced technology nodes requiring 60-90 lithography steps [7][10] - The lithography market is dominated by three major players: ASML, Nikon, and Canon, with a market size in the hundreds of billions [3.2][4.1] Summary by Sections 1. Lithography Process - Lithography is crucial for defining the minimum line width of chips and directly impacts the performance and process level of semiconductor devices [7][10] - Key parameters in lithography include resolution and overlay accuracy, which are essential for ensuring the precise transfer of patterns onto silicon wafers [14][32] 2. Components of Lithography Machines - Lithography machines consist of several key components, including the light source, illumination system, and projection optics, which are critical for the exposure process [43][45] - The light source provides the energy needed for lithography, with different types such as mercury lamps, excimer lasers, and extreme ultraviolet (EUV) light being used depending on the process requirements [45][48] 3. Lithography Machine Market - The lithography machine market is characterized by a high level of competition among leading manufacturers, with ASML being a dominant player in the EUV segment [3.2][4.1] - The report highlights the evolution of lithography technology, including advancements in light source wavelengths and numerical aperture (NA), which are essential for improving resolution [19][22] 4. Domestic Supply Chain Manufacturers - The report outlines several domestic manufacturers involved in the lithography supply chain, including Shanghai Micro Electronics, Guoke Precision, and Huazhuo Jingke, each specializing in different aspects of lithography technology [4.1][4.2][4.3]